and a break through deal with the geisinger health. regeneron has built into a huge pharmaceutical company, it needs to have giant human samples to do the sequencing. so it can invent the drugs of tomorrow. with geisinger regeneron gets the concept of 40,000 human test subjects especially when most have trouble of getting concept of 10 to 20 people. remember, they're one of the four horsemen of the apocalypse and sanifi doesn't want to end up as regeneron road kill or how about alger. here's a company you may know as the purveyor of breast implants but it has a top notch eye c car -- care business. last summer with it stock flying high at $115 and there could be a generic challenge well before anyone expected it. algeren plunged from 115 to 85 so the ceo told us that there'd be real hurdles to any generic challenge. guess what? pyatt was dead right. the generic challenge was far more difficult than the rumor monger said. brand new ones which is algeren went up today. guy came on, promised us this, and there was no reason to doubt him.

glenn steele, president and ceo of geisinger health system. then we have a medicare trustee and former director of the congressional budget office and urban institute. community catalyst. several other members who were not able to be with us today include simon stevens from cohen,health, jay , and lloyd dean with dignity health. say a specialo thanks to our two major funders. first, kaiser permanente. a special appreciation to george halverson. second, to the robert wood johnson foundation represented by andy. i would like to turn the program over to bill ritter, who will outline the role of states in health care cost control and the huge number of policy levers available to states to enhance quality and reduce cost of rate increases over time. governor ritter. [applause] thank you. good afternoon. talking about the state's role and policy levers to moderate health-care cost increases, i want to make a few enteral points. are chapters in our report on the health care problem, health care act, and what the federal government can do to help stat

and glen steele president and ceo of geisinger health system. then we have bob restuccia and medicare -- reischauer a former director of the budget office said urban institute. rob restuccia with community catalyst. several other members who were not able to meet with us today includes simon stevens from united health, j. cowan with optimum, mike davis with general mills, john hanna and very former executive director of the colorado department of health care policy and financing and lloyd dean with dignity health. finally i would like to say a special thanks to our two major funders. first kaiser permanente and special appreciation to george halverson. and second to the robert wood johnson foundation which is represented by andy. now i would like to turn the program over to governor bill ritter who outlined the role of states in health care cost control and the huge number of policy leaders available to states to both enhance quality and reduce the cost of rate increases over time in the health care field. governor ritter. >> thank you. good aft